Also, to verify cell targeting capabilities for different VEGF‐A expression levels in various breast cancer cell lines, MDA‐MB‐231, T‐47D, and MCF10A cells, NPs‐Bev (8 μg mL−1) was cocultured with these cell lines for 4 h. The gene discussed is VEGFA; the disease is breast carcinoma.